Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G filed Feb 17, 2026

Form type

SCHEDULE 13G

Filing date

Feb 17, 2026

Accession number

0001738048-26-000036

Filer

Damora Therapeutics, Inc. (CIK 1800315)